Packages
Each package answers a type of decision. Timing and price are agreed before work starts.
The initial call is used to define the scope; the final price is set in the written proposal, based on the scope. The proposal details the question, the package, the price and the delivery date.
| Package | Question it answers | Timing | From (USD) | Deliverable |
|---|---|---|---|---|
| Argentina High-Cost Monitor | What changed in the quarter in high-cost reimbursement, centralized purchasing, prices and regulation, and what it implies for the portfolio | Quarterly | USD 1,500 per quarter | Report + Excel with the data series + 60-minute session |
| Decision Sprint | One defined market, access or pricing question in one country | 10 business days | USD 6,000 | Decision document + Excel + 60-minute session |
| KHIN Panel | What position payers, opinion leaders or regulators in a country hold, and what decisions they expect to take, regarding a product or a disease area | 20 business days, estimated | USD 9,000 | 8 to 10 interviews, decision document with anonymized quotes + 90-minute session |
| Full Project | Opportunity assessment, business case or access strategy, in one or more countries | 6 to 8 weeks | USD 20,000 | Decision document + final presentation + Excel model + methodology note + 2 working sessions |
| Custom projects | Needs that do not fit the four packages | Per proposal | Per proposal | Per proposal |
Quarterly report on reimbursement, centralized purchasing, prices and regulation for high-cost drugs in Argentina, with implications for the subscriber's portfolio.
From USD 1,500 per quarter
See the package →One defined market, access or pricing question, answered in 10 business days with local evidence and a recommendation.
From USD 6,000
See the package →The position and expected decisions of payers, physicians and regulators in one country regarding a product or a disease area, gathered through anonymous in-depth interviews, in about four weeks.
From USD 9,000
See the package →Opportunity assessment, business case, or access and pricing strategy, with a closed scope, in 6 to 8 weeks.
From USD 20,000
See the package →The four packages cover the most frequent decisions. For needs that do not fit any of them, Kovaris prepares a specific proposal, with scope, timing and price defined for that engagement.
Kovaris works in high-cost and rare diseases, from hematology and specialty immunology to gene therapy, in Argentina, Mexico, Paraguay, Uruguay and Chile. Questions in other therapeutic areas are assessed on the initial call; where the scope falls outside the firm's specialty, this is stated at that stage.
An initial 30-minute call is used to set out the question and the scope; the proposal, with the price and the delivery date, follows in writing.